They also provide guidance to the design of novel therapeutics to inhibit oncogenic B-RAF kinase activity with reduced side effects to the patients
They also provide guidance to the design of novel therapeutics to inhibit oncogenic B-RAF kinase activity with reduced side effects to the patients. ACKNOWLEDGMENTS The work in the Aplin Lab was supported by grants from the National Institutes of Health (“type”:”entrez-nucleotide”,”attrs”:”text”:”GM067893″,”term_id”:”221344151″,”term_text”:”GM067893″GM067893, “type”:”entrez-nucleotide”,”attrs”:”text”:”CA125103″,”term_id”:”35002667″,”term_text”:”CA125103″CA125103), the American Cancer Society (RSG-08-03-01-CSM), and the Pennsylvania Department of Health (AF0301). of…